Literature DB >> 11706657

Hepatitis B and C infections, human immunodeficiency virus and other sexually transmitted infections among women of childbearing age in Côte d'Ivoire, West Africa.

P Combe1, G La Ruche, D Bonard, T Ouassa, H Faye-Ketté, F Sylla-Koko, F Dabis.   

Abstract

Few studies have been conducted in developing countries to estimate the prevalence of hepatitis C virus (HCV) infection and its association with human immunodeficiency virus (HIV) and other sexually transmitted diseases (STDs). We have screened for hepatitis B virus (HBV) and HCV markers 200 HIV-1-positive, 23 HIV-2-positive and 206 HIV-negative women attending gynaecology clinics in 1995/96 in Abidjan, Côte d'Ivoire, a sample selected among 2198 consecutive consultants. Taking into account the prevalence of 21.7% for HIV in this population, the overall prevalence of anti-HBV core antibody was 81.6%, that for hepatitis B surface antigen was 9.9% and for HCV antibody was 3.3%. HIV infection and other STDs were not associated with HBV or HCV markers. Moreover, HBV and HCV markers were not statistically associated. Our results confirm the high prevalence of HIV in Abidjan and the endemic situation of HBV infection. Furthermore, HCV infection is not infrequent in this developing country setting, not explained by sexual transmission.

Entities:  

Mesh:

Year:  2001        PMID: 11706657     DOI: 10.1016/s0035-9203(01)90015-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  6 in total

1.  Prevalence of hepatitis B and hepatitis C coinfections in an adult HIV centre population in Gaborone, Botswana.

Authors:  Premal Patel; Stephanie Davis; Michael Tolle; Vincent Mabikwa; Gabriel Anabwani
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

2.  Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa.

Authors:  Daniel Candotti; Jillian Temple; Francis Sarkodie; Jean-Pierre Allain
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

3.  Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients.

Authors:  Koffi Alain Attia; Serge Eholié; Eugène Messou; Christine Danel; Sandrine Polneau; Henri Chenal; Thomas Toni; Myreille Mbamy; Catherine Seyler; Naomi Wakasugi; Thérèse N'dri-Yoman; Xavier Anglaret
Journal:  World J Hepatol       Date:  2012-07-27

4.  Epidemiology of human immunodeficiency virus-1 and hepatitis B virus co-infection and risk factors for acquiring these infections in the Fako division of Southwest Cameroon.

Authors:  Lauren Shevell; Henry Dilonga Meriki; Fidelis Cho-Ngwa; Crystal Fuller
Journal:  BMC Public Health       Date:  2015-10-17       Impact factor: 3.295

5.  Prevalence of hepatitis C among HIV-1, HIV-2 and dually reactive patients: A multi-country cross-sectional survey in West Africa.

Authors:  Didier K Ekouevi; Patrick A Coffie; Boris K Tchounga; Armel Poda; Antoine Jaquet; François Dabis; Serge P Eholie
Journal:  J Public Health Afr       Date:  2018-10-10

6.  Intra-host diversity and evolution of hepatitis C virus endemic to Côte d'Ivoire.

Authors:  Joseph C Forbi; David S Campo; Michael A Purdy; Zoya E Dimitrova; Pavel Skums; Guo-liang Xia; Lili T Punkova; Lilia M Ganova-Raeva; Gilberto Vaughan; Yousr Ben-Ayed; William M Switzer; Yury E Khudyakov
Journal:  J Med Virol       Date:  2014-02-12       Impact factor: 2.327

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.